Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 84,474 | 83,746 | 79,711 | 72,648 | 62,630 |
| Cost of Goods | 51,740 | 53,636 | 50,321 | 47,507 | 44,218 |
| Gross Profit | 32,734 | 30,110 | 29,391 | 25,141 | 18,412 |
| Operating Expenses | 55,436 | 51,923 | 42,266 | 40,116 | 22,449 |
| Operating Income | -21,962 | -21,177 | -12,555 | -14,468 | -3,819 |
| Interest Expense | 0 | 0 | 0 | 0 | 263 |
| Other Income | -650 | 182 | 186 | 27 | -189 |
| Pre-tax Income | -22,611 | -20,996 | -12,369 | -14,441 | -4,271 |
| Income Tax | -2,245 | -151 | 160 | -2,371 | 70 |
| Net Income Continuous | -20,367 | -20,845 | -12,530 | -12,070 | -4,340 |
| Net Income Discontinuous | -17,741 | -18,927 | -11,435 | N/A | N/A |
| Net Income | $-38,108 | $-39,772 | $-23,964 | $-12,070 | $-4,340 |
| EPS Basic Total Ops | -1.48 | -1.62 | -1.40 | -0.97 | -0.49 |
| EPS Basic Continuous Ops | -0.79 | -0.85 | -0.73 | -0.97 | -0.49 |
| EPS Basic Discontinuous Ops | -0.69 | -0.77 | -0.67 | N/A | N/A |
| EPS Diluted Total Ops | -1.48 | -1.62 | -1.40 | -0.97 | -0.49 |
| EPS Diluted Continuous Ops | -0.79 | -0.85 | -0.73 | -0.97 | -0.49 |
| EPS Diluted Discontinuous Ops | -0.69 | -0.77 | -0.67 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.73 | -1.62 | -1.40 | -0.97 | -0.47 |
| EBITDA(a) | $-18,051 | $-17,234 | $-8,834 | $-11,172 | $-1,182 |